Transcranial recount newest stimulation (tDCS) is efficient and ranking for migraine, in response to a overview published online April 19 in CNS Neuroscience and Therapeutics.
Peiwei Hong, from Sichuan College in Chengdu, China, and colleagues conducted a systematic overview and meta-diagnosis of randomized controlled trials (RCTs) to spy the efficacy and safety of tDCS for migraine. The meta-diagnosis included 11 RCTs with 425 patients with migraine. The RCTs examined the efficacy and safety of anodal or cathodal stimulation concentrated on a bunch of mind areas, in conjunction with the predominant motor cortex (M1), predominant sensory cortex (S1), dorsolateral prefrontal cortex (DLPFC), and visual cortex (VC).
The researchers found that in patients with migraine, the different of migraine days per month was once reduced with tDCS with M1 and VC activation. Migraine anxiety depth would possibly per chance more than likely more than likely also be improved with tDCS with activation of DLPFC and M1. tDCS with VC inhibition would possibly per chance more than likely more than likely also moreover slash aid the different of migraine days per month. Pain depth would possibly per chance more than likely more than likely also be reduced with tDCS with inhibition of M1, S1, and VC. No incompatibility in the incidences of adverse events was once considered between the active stimulation and sham stimulation groups.
“Our results showed that both activating or inhibiting M1 or VC would possibly per chance more than likely more than likely also strengthen migraine prognosis,” the authors write. “Meanwhile, activating the DLPFC or inhibiting S1 would possibly per chance more than likely more than likely also strengthen migraine prognosis.”
More recordsdata:
Peiwei Hong et al, Transcranial recount newest stimulation for migraine: a systematic overview and meta?diagnosis of randomized controlled trials, CNS Neuroscience & Therapeutics (2022). DOI: 10.1111/cns.13843
© 2022 HealthDay. All rights reserved.
Citation:
Evaluate: Transcranial recount newest stimulation eases migraine (2022, April 29)
retrieved 2 Can also 2022
from https://medicalxpress.com/info/2022-04-transcranial-newest-eases-migraine.html
This doc is subject to copyright. Moreover any excellent dealing for the cause of private see or be taught, no
portion would possibly per chance more than likely more than likely be reproduced with out the written permission. The sigh material is supplied for recordsdata purposes excellent.
Discover more from GLOBAL BUSINESS LINE
Subscribe to get the latest posts sent to your email.
